ATLANTA--(BUSINESS WIRE)--MIV Therapeutics Inc. (OTCBB:MIVT) (FWB:MIV), a leading developer of next-generation biocompatible coatings and advanced drug delivery systems for cardiovascular stents and other implantable medical devices, has announced the online availability of an updated Investor Fact Sheet detailing the Company’s high-growth business model, as well as recent strategic achievements, including the recent acquisition of India-based Biosync Scientific, along with eight CE-marked products and a world-class senior management team and advisory board.
